Neuroimaging of exogenous tracer extravasation has become the technique of choice in preclinical and clinical studies of blood-brain barrier permeability. Such tracers have a larger molecular weight than small ions, neurotransmitters and many drugs. Therefore, it is assumed that tracer extravasation indicates both permeability to these and the cancelation of the electrical polarization across the barrier. Electrophysiological anomalies following intracarotideal administration of dehydrocholate, a bile salt causing extravasation of the albumin-binding tracer Evans blue, seemingly supported this. By contrast, electron microscopic studies suggested a different hierarchical pattern of blood-brain barrier dysfunction, a milder degree of impairment being characterized by increased function of the transcellular pathway and a severe degree by opening of the tight junctions. This would imply that the extravasation of macromolecules can occur before disruption of the electrical barrier. However, functional evidence for this has been lacking. Here, we further investigated the electrophysiological anomalies following intracarotideal application of dehydrocholate in rats and found that it caused focal cerebral ischemia by middle cerebral artery thrombosis, the electrophysiological recordings being characteristic of long-lasting spreading depolarization. These observations indicated that intracarotideal dehydrocholate is not a suitable model to study the isolated dysfunction of the blood-brain barrier. Second, we studied the topical application of dehydrocholate to the brain and the application of mannitol into the carotid artery. In both models, we found significant extravasation of Evans blue but no changes in either extracellular potassium or the CO 2 -dependent intracortical direct current deflection. The latter is assumed to depend on the proton gradient across the barrier in rats which we confirmed in additional experiments in vivo and in vitro. The stability of the extracellular potassium concentration and the CO 2 -dependent direct current deflection are two functional tests which indicate the integrity of the electrical barrier. Hence, our results provide functional evidence that the blood-brain barrier opening to large molecules does not necessarily imply the opening to small ions consistent with the hierarchy of damage in the previous electron microscopic studies.
Introduction
In 1885, Paul Ehrlich showed the lack in permeability of brain vessels to dyes, and, in 1900, Max Lewandowsky postulated a barrier between blood and neuronal tissue, the so called blood-brain barrier (BBB) (Ehrlich, 1885; Lewandowsky, 1900) . Under physiological conditions, the restrictive nature of the BBB hinders most polar solutes and macromolecules larger than 400 to 500 Da to enter the brain's extracellular space (Fig. 1) .
It is often assumed that the transfer of hydrophilic molecules across the dysfunctional BBB largely depends on their size. The basis of this concept is that the dysfunction of the BBB occurs on the level of the junctional complexes of which disruption is indeed characterized by a size-dependent paracellular passage of molecules into the brain as shown in experiments with homozygous claudin-5 knockout mice (Nitta et al., 2003) . This concept implies that BBB opening to macromolecules such as albumin is associated with opening to small ions such as potassium and protons. Experiments with the bile salt sodium dehydrocholate (DHC) seemingly supported this. When injected into the carotid artery, DHC caused extravasation of the albumin-binding dye Evans blue (Spigelman et al., 1983) , and, electrophysiological recordings revealed marked persistent changes in the direct current (DC) potential associated with drastically diminished, subsequent CO 2 -dependent DC deflections (Nita et al., 2004) . Neurobiology of Disease 52 (2013) [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] These electrophysiological anomalies were regarded as a consequence of BBB opening to small ions, canceling the electrical polarization across the BBB. Normally, the electrical polarization produces a resting potential difference of~4 mV between intravascular and interstitial compartment (Revest et al., 1994) .
Hyperosmolar agents such as mannitol are another experimental tool causing dysfunction of the BBB. Mannitol was indeed shown to cause functional changes in key components of the junctional complexes such as β-catenin which could lead to the junctions' opening (Farkas et al., 2005) . However, previous electron microscopic studies Fig. 1 . Anatomical structure of the BBB. (A) The BBB is characterized by endothelial cells that have no fenestrae and minimal transcytotic vesicles but mitochondria in abundance. They line the inner luminal surface of the vessels and are fastened together by continuous, belt-like endothelial cell-cell complexes of adherens and tight junctions (inset). The tight junctions are composed of a complex of proteins, including transmembrane proteins (claudins and occludins), and zonula occludens proteins (ZO 1, 2, and 3), which bind the transmembrane proteins to the actin/myosin cytoskeleton. The junctional adhesion molecules (JAM) are members of the immunoglobulin superfamily and appear to act as cell-adhesion molecules for leukocytes (Abbott et al., 2010) . The adherens junctions include vascular endothelial cadherin (VE-cadherin) which support a structural maintenance of the BBB and the formation of tight junctions and catenins that link cadherins to skeleton proteins as well as platelet-endothelial cell adherens molecule (PECAM). Additional cellular elements of the BBB are pericytes which share with the endothelial cells a common capillary basement membrane and astrocytic foot processes which cover the capillaries (Abbott et al., 2006; Beard et al., 2011; Neuwelt et al., 2011) . (B) While the paracellular pathway is normally blocked by the junctional complexes, the trafficking of essential solutes across the BBB either into or out of the brain parenchyma occurs by the transcellular pathway, mediated and controlled through specific transport or carrier molecules in a highly selective fashion. Dysfunction of the BBB occurs in many brain diseases, including stroke, epilepsy, trauma, infectious and degenerative disorders (Abbott et al., 2006; Cornford and Oldendorf, 1986; Korn et al., 2005; Neuwelt et al., 2011; Stanimirovic and Friedman, 2012; Tomkins et al., 2001) . While it has long been recognized that BBB dysfunction is associated with brain diseases, only recently the BBB has been suggested as active player in epileptogenesis and neurodegeneration Marchi et al., 2007; Seiffert et al., 2004; Tomkins et al., 2007; van Vliet et al., 2007). on the microvascular pathology following hyperosmolar solutions suggested a different hierarchical pattern of BBB dysfunction. The milder degree of impairment appeared to be the leakage of intravascular molecules into the brain's extracellular space by increased function of the transcellular pathway due to vesicular transcytosis and formation of transendothelial channels (Farrell and Shivers, 1984; Houthoff et al., 1982) . More severe damage was characterized by the disruption of tight junctions with widened interendothelial junctional clefts, partially fragmented, necrotic endothelial cells in the process of desquamation, vasospastic smooth muscle cells and platelet activation with attached microthrombi in some arterial segments (Lossinsky et al., 1995) . To our knowledge, the functional evidence for this hierarchy of damage has been lacking. If such a hierarchy occurs, the milder degree of BBB dysfunction should be characterized by the extravasation of macromolecules through increased function of the transcellular pathway in the presence of a closed electrical barrier. The electrical barrier between intravascular and interstitial compartment is characterized by selective permeabilities to small ions in a similar fashion to cellular membranes. Hence, the disruption of the electrical barrier would imply either the opening of tight junctions or the lysis of endothelial cells.
Therefore, we investigated the electrophysiological responses induced by intracarotideal DHC in rats in more detail and found that they are secondary to cerebral ischemia. This implied that intracarotideal application of DHC is not a suitable model to study the isolated dysfunction of the BBB. We then investigated further whether the CO 2 -dependent intracortical DC deflection in rats, the slowly changing potential difference between the brain extracellular space and an external reference, is a diffusion potential across the BBB determined by the product of a constant and the proton gradient between intravascular and interstitial compartment (Tschirgi and Taylor, 1958) , and can thus be used as functional marker for the intact electrical barrier. Finally, we studied whether opening of the BBB to Evans blue by either topical application of DHC to the brain or intracarotideal infusion of mannitol is associated with (i) a rise in the extracellular potassium concentration ([K   + ] o ), and (ii) a loss of the CO 2 -dependent intracortical DC deflection as two independent functional tests for the integrity of the electrical barrier.
Materials and methods

In vivo experiments, animal preparation
All animal experiments were approved by the Governmental Animal Care and Use Committee (Landesamt für Arbeitsschutz, Gesundheitsschutz und technische Sicherheit Berlin). The animals were housed in groups (two to four animals per cage) under a 12-hour light-dark cycle with food and tap water available ad libitum. Hundred and nineteen male Wistar rats (250-400 g; Charles River Laboratories, Wilmington, MA, USA) were anesthetized with 100 mg/kg thiopental-sodium intraperitoneally (Trapanal, BYK Pharmaceuticals, Konstanz, Germany), tracheotomized, and artificially ventilated (Effenberger Rodent Respirator, Effenberger med.-Techn. Gerätebau, Pfaffing/Attel, Germany). Another ten male Wistar rats were anesthetized with isoflurane (1.5% to 2.0% in 30% O 2 and 70% N 2 O) and allowed to breathe spontaneously. Wounds were treated with lidocainehydrochloride gel (2%; Astra GmBH, Wedel, Germany). End-expiratory CO 2 pressure (Heyer CO 2 Monitor EGM I, Bad Ems, Germany) was adjusted to~35 mm Hg. Body temperature was maintained at 38.0 ± 0.5°C using a heating pad (Temperature Control FHC, Bowdoinham, ME, USA). The left femoral artery was cannulated to monitor the systemic arterial pressure (Pressure Monitor BP-1, World Precision Instruments, Berlin, Germany) and the femoral vein to administer Evans blue. Serial blood gas analyses were performed to measure arterial partial pressure of O 2 (p a O 2 ), arterial partial pressure of CO 2 (p a CO 2 ) and pH using a Compact 1 Blood Gas Analyzer (AVL Medizintechnik GmbH, Bad Homberg, Germany). The level of anesthesia was controlled by assessing motor and blood pressure responses to tail pinch and if necessary, additional doses of thiopental (25 mg/kg) were applied or isoflurane was increased in the inspired air. Animals were immediately killed after the experiment by intravenous administration of concentrated KCl solution unless they died spontaneously as stated in the Results section.
Cranial window preparation
A 5 × 4 mm cranial window was performed over the somatosensory cortex using a saline-cooled drill as described previously (Fig. 2C ) (Dreier et al., 2002; Oliveira-Ferreira et al., 2010) . In 120 animals, the cranial window was open which allowed the placement of ionselective microelectrodes. In 9 animals, the window was closed and covered with a glass slip to image the pial arterioles using a CCD camera (Leica DFC300 FX Digital Color Camera, Leica Microsystems AG, CH-9435, Heerbrugg, Switzerland) connected to the microscope (Leica MZ16 FA, Leica Microsystems) and using Leica Application Multifocus module software. In animals equipped with a closed cranial window and 95 animals with an open window, the dura mater was removed to expose the cortex to artificial cerebrospinal fluid (aCSF) (preparation type 2) whereas in the remaining 25 animals with an open window only two slits were cut in the dura to position the microelectrodes Fig. 2 . Intracarotideal application of DHC (17.5%, 1 ml). (A and B) Cannulation of the external carotid artery (ECA) in a retrograde manner for the application of drugs to the internal carotid artery (ICA). After the skin incision, the sternomastoid and paratracheal muscles (M) were retracted with silk sutures to open the triangle-shaped area between the sternomastoid, paratracheal, and digastric muscles which contains the carotid artery and its branches. A small lateral part of the hyoid bone was removed to improve the visibility. The medially located vagus nerve was separated from the common carotid artery (CCA). The superior thyroid artery (STA), which comes off the external carotid artery and runs medial to it as well as the posterolaterally located occipital artery (OA), which normally branches from the carotid bifurcation, were ligated with a silk suture. Moreover, the pterygopalatine artery (PA), the lateral branch of the internal carotid artery, which does not supply the brain, was ligated to ensure that drugs injected into the catheter will be delivered to the brain. Two sutures were looped around the external carotid artery to close the vessel in a reversible manner by gently pulling the sutures upward. Subsequently, a small incision was made in the external carotid artery between the two sutures and a polyethylene catheter was inserted in a retrograde manner. The catheter was pushed further toward the bifurcation. Eventually, the knots of the sutures were tied and a saline solution, warmed-up to body temperature, was continuously infused through the catheter to keep it open. (C) In 120 animals, an open cranial window was established caudally. The dura mater was cut and the cortical surface exposed to aCSF. One or two glass microelectrodes were positioned to record changes in intracortical DC-ECoG, [K + ] o or pH. In addition, the subdural DC-ECoG was measured with an Ag/AgCl wire (not shown) and rCBF with a laser-Doppler flow probe (LDF 2). The epidural DC-ECoG was recorded rostrally with an Ag/AgCl electrode on the dura. Neighboring this electrode, another laser-Doppler flow probe measured rCBF (LDF 1). In some experiments, SD was artificially triggered at a small lateral window by either pinprick or KCl (3 M) solution and propagated from this window to the medially located recording sites. (D) Near-complete arrest of the pial arterial circulation after intracarotideal application of DHC (experiment with a closed cranial window). Note the paleness of the cortex and the massive constrictions of the pial artery in the window area (arrows) after DHC. (E) Representative brain slice of an animal in which Evans blue was administered before intracarotideal injection of DHC. Note the extravasation of Evans blue in both hemispheres. (F) The post mortem analysis revealed a thrombosis of the ipsilateral middle cerebral artery and its branches after intracarotideal DHC. (G) Multimodal neuromonitoring during intracarotideal DHC application indicated changes typical of focal cerebral ischemia. In response to DHC, rCBF showed first an increase followed by a marked long-lasting drop. The mean arterial pressure increased simultaneously with the drop in rCBF typical of a systemic hypertension which aims at compensating for the focal cerebral ischemia. After the drop in rCBF, [K + ] o displayed first a shallow increase followed by a sudden, marked and long-lasting increase to~50 mM typical of an SD in ischemic tissue. The SD is observed as a large negative change (~20 mV) in the intracortical DC-ECoG recordings. Similar to the intracortical recordings, the epidural (extracerebral) electroencephalogram (EEG) displayed a long-lasting DC negativity during the SD. The AC component of the electroencephalogram showed first epileptic spikes after the drop in rCBF followed by a silencing of the spontaneous activity when the SD started. (H) The epileptic spikes are given at a higher temporal resolution. (I) At a higher temporal resolution, it can also be seen that the SD ran from the rostral to the caudal microelectrode. It was not possible however to determine the propagation velocity because the exact point remained unknown where the SD originated after the intracarotideal DHC application.
(preparation type 1) (Fig. 3) . The cortical surface was continuously superfused with aCSF containing in mM: 127.5 NaCl, 24.5 NaHCO 3 , 6.7 urea, 3.7 glucose, 3 KCl, 1.5 CaCl 2 , and 1.2 MgCl 2 . The aCSF was equilibrated with a gas mixture containing 6% O 2 , 5.9% CO 2 , and 87.5% N 2 to achieve physiological levels of pO 2 , pCO 2 and pH. Levels of pO 2 between 90 and 130 mm Hg, pCO 2 between 35 and 45 mm Hg, and pH between 7.35 and 7.45 were accepted as physiological.
To measure epidural field potential changes, a second small window (∅2 mm) was rostrally established where the dura remained intact and an Ag/AgCl electrode was placed on the dura (Fig. 2C) . Neighboring this electrode, the bone was thinned to position an additional laser-Doppler flow probe.
SD was triggered at a small, lateral cranial window as shown in Fig. 2C by either pin prick (n = 4) or a drop of concentrated KCl (3 M) solution (n = 5).
Cannulation of the external carotid artery
In 32 animals, the right external carotid artery was cannulated in a retrograde manner, as described by Bullard et al. (1984) and explained in Figs. 2A and B. The retrograde cannulation of the external carotid artery allowed the infusion of DHC (n = 16) or mannitol (n = 16) into the internal carotid artery.
Animal recording techniques
Regional cerebral blood flow (rCBF) was continuously monitored with one laser-Doppler flow probe (Periflux 4001, Perimed, Järfälla, Sweden) at the caudal cranial window and another optional probe at the rostral recording site (Fig. 2C) . The subdural DC/alternating current (AC)-electrocorticogram (ECoG) (bandpass: 0-45 Hz) at the caudal window (Dreier et al., 2002) and the epidural DC/AC-ECoG at the rostral window were measured with Ag/AgCl electrodes. In the closed cranial windows, the subdural electrode was placed in the space between the cortex and the coverslip. Changes in [K + ] o , the extracellular pH and the intracortical DC/AC-ECoG (bandpass: 0 to 45 Hz) were recorded in a cortical depth of 300 μm with ion-selective microelectrodes which were prepared and tested as described previously from double-barreled thetaglass capillaries (Kugelstätter, Garching, Germany) (Heinemann and Arens, 1992; Lux and Neher, 1973; Windmuller et al., 2005) . Potassium ionophore I-cocktail A and hydrogen ionophore I-cocktail A (Fluka/ Sigma-Aldrich) ion exchangers were used for manufacturing potassiumand pH-selective microelectrodes, respectively. An Ag/AgCl ground electrode was placed in the neck. The electrodes were connected to a differential amplifier (Jens Meyer, Munich, Germany). Analog-to-digital conversion was performed using a Power 1401 (Cambridge Electronic Design Limited, Cambridge, UK). Systemic arterial blood pressure as well as local cerebral ion, voltage and rCBF changes were continuously recorded using a personal computer and Spike 2 software (version 6, Cambridge Electronic Design Limited).
Experimental paradigms
Hypercapnic episodes were induced by ventilation with a gas mixture containing 21% O 2 , 10% CO 2 , and 69% N 2 for 5 min. Further details of the experimental paradigms are given in the Supplemental material and methods (1: Experimental paradigms of intracarotideal DHC infusion, topical application of DHC to the brain and intracarotideal mannitol infusion, assessment of Evans blue extravasation). Moreover, the experimental paradigms of these experiments and the experimental paradigm of the pharmacological experiments are given in Supplemental Fig. 1 .
Brain slices
For in vitro electrophysiological recordings, male Wistar rats (250-400 g, n = 6) were deeply anesthetized with isoflurane and decapitated. Brains were quickly removed, and coronal slices of 400 μm thickness were prepared from the somatosensory cortex using a vibrating-blade tissue slicer (Vibroslice, Campden Instruments, Loughborough, UK). Slices were perfused with prewarmed aCSF in an interface-type recording chamber and maintained in a humidified, carbogenated (95% O 2 and 5% CO 2 ) atmosphere at 34.5°C. The composition of the aCSF was (in mM): 129 NaCl, 21 NaHCO 3 , 10 glucose, 3 KCl, 1.8 MgSO 4 , 1.6 CaCl 2 , and 1.25 NaH 2 PO 4 . Prior to the onset of the recordings, the tissue was given time to recover from the preparation procedure for at least 1 h (Kirov et al., 1999; Schurr et al., 1984; Taylor et al., 1999) . To ensure viability of the tissue, evoked field potentials in neocortical layers II/III were assessed after stimulation at the boundary of layer VI to the subjacent white matter using a bipolar platinum electrode. Slices were accepted for further investigation if the field potential was at least 1.5 mV in amplitude. In order to simultaneously measure extracellular changes in field potential (DC/AC-ECoG), [K + ] o , [Ca 2+ ] o as well as pH, potassium, calcium and pH-selective microelectrodes were prepared and tested as mentioned above. Calcium ionophore I-cocktail A (Fluka/Sigma-Aldrich) ion exchanger was used for manufacturing the calcium-selective microelectrodes. To test the effects of extracellular acidification caused by increased ambient pCO 2 , the gas mixture was switched every 5 min from 80% O 2 , 5% CO 2 , and 15% N 2 to 80% O 2 , 20% CO 2 and 0% N 2 .
Data analysis and statistics
DC-potentials were analyzed as absolute changes and rCBF was calculated as percentage change from baseline (= 100%). Ion concentration changes were calculated from the voltage changes using the Nernst equation. P b 0.05 was accepted as statistically significant. Details of the statistical analysis are given in the text below.
Results
Intracarotideal application of DHC causes focal cerebral ischemia
It has been shown previously that intracarotideal application of DHC (17.5%, 1 ml) causes Evans blue dye extravasation in rats (Spigelman et al., 1983) . Electrophysiological recordings at the scalp in cats revealed that a similar protocol of intracarotideal DHC administration generated electrophysiological anomalies which could indicate the cancelation of the electrical potential across the BBB (Nita et al., 2004) .
To further characterize the electrophysiological responses to intracarotideal application of DHC (17.5%, 1 ml, infused over 1 min (Spigelman et al., 1983 Intracarotideal DHC induced a short initial increase of rCBF to 365 (274, 413) % (median, first and third quartile) in all 6 experiments followed by a marked drop to 27 (25, 41) % after 31 (27, 86) s in 5 of 6 experiments ( Fig. 2G) . A shallow increase in baseline [K + ] o from 3 to 8.5 (5.6, 11.9) mM started simultaneously with the decrease in rCBF. This was accompanied by ictal epileptic field potentials with an amplitude of − 2.4 (− 1.7, − 5.2) mV, a spike duration of 65 (63, 68) ms, and a spike frequency of 0.9 (0.6, 1.8) Hz (Fig. 2H) followed by a suppression of spontaneous activity. Moreover, a significant increase of mean arterial pressure from 137 (109, 150) to 200 (193, 203) mm Hg (P b 0.001, n = 5, Paired t-test) accompanied the decrease in rCBF typical of a compensatory systemic hypertension. In all five animals, which displayed a drop in rCBF, 32 (21, 74) s after its onset, we observed a sharp saddle-shaped negative intracortical DC shift with an amplitude of − 20.5 (− 18.9, − 22.0) mV accompanied by a steep increase in [K + ] o to 53.5 (40.9, 57.4) mM typical of a spreading depolarization (SD) in ischemic tissue (Dreier, 2011; Hansen and Lauritzen, 1984) (Fig. 2G ). This intracortical DC shift spread between the rostral and the caudal microelectrode with a latency of 13 (4, 39) s typical of SD (Fig. 2I ). Epidural recordings, performed remotely from the open cranial window, showed first a positive DC shift of 0.6 (0.2, 1.0) mV which accompanied the onset of the rCBF decrease. After 31 (24, 78) s, this epidural DC positivity was succeeded by a negativity of − 3.2 (− 7.2, − 2.6) mV which persisted until the end of the experiment (Fig. 2G) .
Three of the five animals were sacrificed after an observational period of 60 min during which the DC negativity, the elevated level of [K + ] o and the suppression of spontaneous activity had not recovered. The remaining two animals died 7.3 and 10.7 min after DHC application. Marked Evans blue dye extravasation was observed in the whole brain in all animals (Fig. 2E) .
For a comparison with the ischemic SDs following intracarotideal DHC, we recorded a pinprick-induced SD under physiological conditions in four additional rats. This SD was characterized by a sharp negative intracortical DC-shift of − 16.7 (− 16.4, − 17.2) mV lasting for 85 (81, 97) s, a steep rise in [K + ] o to 59.0 (50.7, 67.6) mM and a transient rise of rCBF to 250 (241, 256) %. After the spreading hyperemia, rCBF showed a long-lasting spreading oligemia to 84 (81, 87) %. Epidurally, the SD was associated with a small initial negative DC shift of − 0.3 (− 0.6, − 0.2) mV lasting for 67 (57, 100) s followed by a persistent positive DC shift of 2.3 (2.0, 2.8) mV lasting for at least 64 (52, 67) min as shown in Fig. 4A .
Subsequently, we tested the infusion of lower concentrations and volumes of DHC into the carotid artery. Because we aimed at performing a histological analysis to assess the ischemic injury 24 h after the infusion of DHC, the animals were anesthetized with isoflurane in these experiments, and they were not tracheotomized but breathed spontaneously, which would have allowed us to wake them up after the experiment. But, the animals died 7.1 (5.4, 10.3) min, 10.2 (8.0, 11.7) min and 20.1 min after administration of DHC 17.5% (0.5 ml, n = 4), DHC 15% (0.5 ml, n = 5) and DHC 10% (0.5 ml, n = 1), respectively. All animals showed subdural DC/AC-ECoG and rCBF changes typical of focal cerebral ischemia before they died (data not shown).
Subsequently, we implanted a closed cranial window in 9 animals to image the pial vascular changes following intracarotideal application of DHC. All animals showed subdural DC/AC-ECoG and rCBF changes typical of focal cerebral ischemia before they died (data not shown). Videomicroscopy revealed an arrest of the pial circulation following DHC (Fig. 2D) . After the experiment, the animals were transcardially perfused with 150 ml of physiological saline solution. Post mortem analysis of the brains revealed a thrombosis of the ipsilateral middle cerebral artery and its branches (Fig. 2F ). These Fig. 3 . Association between the type of the rCBF response to hypercapnia and the type of the dura defect at the cranial window. At the bottom, the position of the caudal cranial window in relation to the brain is depicted. The cranial window is surrounded by a wax wall and dental cement. Above, on the left side, the type 1 preparation is given in which only two small slits (red arrow) were cut in the dura (thick black layer and black arrow) to position the microelectrodes, whereas, on the right side, the type 2 preparation is given in which the dura was removed to expose the cortex to the aCSF. At the top of the figure, a contingency table is shown in a monitor which displays the hyperemic rCBF responses to hypercapnia in the upper row and the hypoemic rCBF responses in the lower row while the columns give the two different preparation types. According to the distribution in the four fields, the hyperemic type 1-rCBF response to hypercapnia was significantly associated with the preparation type 1 and the hypoemic type 2-rCBF response with the preparation type 2 (P = 0.001, n = 95, Chi-Square test with Yates correction for continuity). healthy tissue during SD. The SD was followed by a long-lasting spreading oligemia. Notably, the epidural DC potential (green trace) showed an initial short-lasting negativity followed by a positivity. The latter appeared to accompany the spreading oligemia and lasted for more than 1 h. (B) Hypercapnic episodes under control conditions. The increase in end-expiratory pCO 2 indicated the hypercapnic episode (upper traces). The physiological hyperemic rCBF change in response to hypercapnia was termed the type 1-rCBF response (upper part) and the unusual hypoemic rCBF change the type 2-rCBF response (lower part) (red traces). Low-frequency vascular fluctuations (LF-VF, bandpass: 0.05-0.1 Hz) and high-frequency vascular fluctuations (HF-VF, bandpass: 0.5-5 Hz) significantly increased during hypercapnia when the normal type 1-rCBF response was observed. By contrast, they showed a strong increase only after the hypercapnic episode when the hypoemic type 2-rCBF response occurred. Whereas the CO 2 -dependent intracortical DC potential was independent of the type of rCBF response to hypercapnia, the CO 2 -dependent epidural DC potential appeared to follow the rCBF changes. The power of the spontaneous activity (AC-EEG and AC-ECoG) only decreased significantly when the type 2-rCBF response occurred. In this example for the type 2-rCBF response, both epidural and intracortical DC/AC-ECoG show a slight decline more than 5 min before the hypercapnia. This is likely an artifact. Asterisk: typical positive CO 2 -dependent intracortical DC shift induced by hypercapnia. In the top row, the same CO 2 -dependent intracortical DC deflection is given at a higher resolution. It is seen that hypercapnia (bar, 5 min) induced a positive intracortical DC deflection with a steep initial increase followed by a plateau and a recovery phase.
findings indicated that intracarotideal DHC is a model for focal cerebral ischemia in rats and cannot be used to selectively study the opening of the electrical barrier.
The CO 2 -dependent intracortical DC deflection in the rat does not depend on changes in rCBF Next, we investigated whether and how the CO 2 -dependent intracortical DC deflection is generated at the BBB in rats, and whether it can be used as a functional tool to assess the integrity of the electrical barrier (Tschirgi and Taylor, 1958) .
Notably, there are important species differences in the CO 2 -dependent intracortical DC deflection. Whereas rats, rabbits, goats and dogs displayed a positive DC deflection in response to hypercapnia, which depended in a linear fashion on the proton gradient across the BBB, cats and monkeys displayed a negative DC deflection, which appeared to depend on the level of rCBF Held et al., 1964; Messeter and Siesjo, 1971; Tschirgi and Taylor, 1958; Woody et al., 1970 ). However, whether the level of rCBF also influences the CO 2 -dependent intracortical DC deflection in rats has not been investigated. In the present study, we were able to exclude this possibility by an artifact related to the size of the dura defect in our open cranial window preparations.
Thus, we did not only observe the normal hyperemic response to hypercapnia (type 1) in 53 animals but also an unusual, mildly hypoemic response (type 2) in 42 animals. In all 95 experiments, animals were anesthetized with thiopental, artificially ventilated and equipped with an open cranial window, rCBF was measured at this window, the first hypercapnic episode occurred under control conditions and this hypercapnic episode was indicated by a marked increase in end-expiratory pCO 2 (Fig. 4B) .
The two different types of rCBF responses are shown in Fig. 4B and compared in Table 1B . In addition to the abnormal hypoemic rCBF change, the type 2 response was characterized by a significant hypercapnia-associated reduction in the power of spontaneous activity (Table 1B3) . Table 1A gives the pooled changes in the systemic parameters during the first control episode of hypercapnia for both the group of animals, which displayed the type 1-rCBF response, and the group of animals, which displayed the type 2-rCBF response. No significant differences in the changes of the systemic parameters during hypercapnia were found between the two groups (Table 1B1) . This suggested that a local factor at the window site might have been responsible for the different rCBF responses. We therefore investigated whether the two different rCBF responses were associated with the two different preparation techniques for the open cranial window which we had performed in this study. In preparation type 1, only two small slits had been cut in the dura mater to position the microelectrodes in the parenchyma while, in preparation type 2, a larger part of the dura was removed to allow the topical application of drugs to the brain. As illustrated in Fig. 3 , there was a significant association of the type 1-rCBF response with the type 1 preparation and of the type 2-rCBF response with the type 2 preparation, respectively (P = 0.001, n = 95, Chi-Square test with Yates correction for continuity). That the type of rCBF response depended on the type of defect in the dura mater suggests a relation with the mild brain swelling that results from the increase in cerebral blood volume and a mild uptake of water during hypercapnia (Lu et al., 2009; Paljarvi et al., 1982) . This swelling might have caused a compression of the brain at the rim of the dura defect when the defect was larger. Unfortunately, this precluded a further meaningful analysis of hypercapnia-induced changes in rCBF and spontaneous activity in experiments in which preparation type 2 had been performed. The hypercapnia-induced intracortical DC-shift could nevertheless be analyzed in all groups because it did not show any difference between the two types of rCBF responses (Table 1B2) . Notably, this limitation of our study was not only unfavorable. That the hypo-and hyperemic rCBF responses were associated with CO 2 -dependent intracortical DC deflections of the same polarity and magnitude allowed us to exclude the possibility that the intracortical DC deflection is influenced by changes in rCBF in the rat.
In contrast to the CO 2 -dependent intracortical DC deflection, the CO 2 -dependent epidural DC deflection, an extracerebrally recorded volume conducted signal which is modified by extracerebral factors, showed a clear dependence on the type of rCBF response. Whereas the epidural DC deflection associated with the type 1-rCBF response had the same polarity as the intracortical DC deflection, the epidural DC deflection associated with the type 2-rCBF response had the opposite polarity (Fig. 4B ). These differences were statistically significant (Table 1B2) .
Evidence in vivo against neurons as generators of the intracortical CO 2 -dependent DC deflection (type 2 preparation)
If neurons generated the hypercapnia-induced positive, intracortical DC-shift in a similar fashion to an extracellular field postsynaptic potential, hypercapnia should induce an uneven, zonal hyperpolarization of the neurons leading to axial and net transmembrane currents. Hyperpolarization could result from activation of neuronal K + channels. We therefore tested in vivo the effect of amiloride (n= 6), an inhibitor of acid-sensing ion channels, and of inhibitors of major K + channels on the hypercapnia-induced intracortical DC shift. Specifically, we applied tolbutamide (n= 5), an inhibitor of ATP-sensitive K + channels, apamin (n=5), an inhibitor of small conductance Ca
2+
-sensitive K + channels (SK) and tetraethylammonium (TEA) (n= 5), an inhibitor of big conductance Ca
-sensitive K + channels (BK). However, neither sham controls nor animals, in which these channel blockers were topically applied to the brain, showed any difference between the hypercapniainduced intracortical DC-shift associated with the first control episode of hypercapnia and the second episode of hypercapnia after drug application. The effects of these drugs on baseline [K + ] o are shown in Table 1C .
Evidence in vivo against astrocytes as generators of the intracortical CO 2 -dependent DC deflection (type 2 preparation) DC potentials can also result from current flow driven by inhomogeneous polarization across the glial syncytium (Dietzel et al., 1989; Orkand et al., 1966) . Such DC-shifts depend on potassium and chloride uptake by astrocytes. We therefore tested in vivo whether a major inhibitor of potassium uptake by astrocytes and a chloride channel blocker would change the CO 2 -dependent intracortical DC deflection in vivo. Specifically, we applied barium, an inhibitor of inwardly rectifying K + channels (n = 6), and DIDS, an inhibitor of astrocytic Cl − channels (n = 5) (Walz and Wuttke, 1999) . None of these drugs had any effect on the intracortical DC deflection. Moreover, we tested the effect of topically applying the Na, K-ATPase inhibitor ouabain to the brain in 6 animals. Ouabain was administered at a concentration of 10 μM in which it selectively inhibits the neuronal α2 and the astrocytic α3 isoforms in rats (Blanco and Mercer, 1998 (Lehmenkühler et al., 1989) . In contrast to the positive hypercapnia-induced intracortical DC deflection in vivo, the brain slices always displayed a small and steady negative hypercapnia-induced intracortical DC deflection of −0.61 (−0.54, −0.71) (Pb 0.001, n =6, Paired t-test, Fig. 5A ). This finding supports the hypothesis that the positive hypercapnia-induced intracortical DC deflection in vivo is generated at the BBB because brain slices lack an intact BBB.
Evidence that the CO 2 -dependent intracortical DC deflection represents a diffusion potential related to the proton gradient across the BBB in rats
Next, we investigated further whether the CO 2 -dependent intracortical DC deflection in rats is a diffusion potential across the BBB determined by the following empirical Nernstian formula (Tschirgi and Taylor, 1958) and can thus be used as a tool to assess the BBB permeability to protons:
In 16 experiments, we measured the intracortical change in pH during hypercapnia using pH-selective microelectrodes (Fig. 5B) . We found a significant decrease by 0.091 (0.021, 0.168) pH units (P = 0.001, Paired t-test). This pH decrease was significantly smaller than the arterial pH decrease of 0.192 (0.162, 0.210) (P b 0.001, n = 80, Mann − Whitney Rank Sum test). The positive CO 2 -dependent DC deflection was 3.1 (2.6, 3.4) mV (n = 95) as recorded with intracortical microelectrodes. Using the empirical formula of Tschirgi and Taylor as mentioned above (Tschirgi and Taylor, 1958) , we calculated a positive CO 2 -dependent intracortical DC deflection of 29 (±5) * (0.192 − 0.091) = 2,9 (2.4, 3.4) mV which included the empirical value above and thus confirmed the findings by Tschirgi and Taylor. Moreover, Tschirgi and Taylor had found a slope of about 17 mV/pH unit for the linear relationship between the positive intracortical CO 2 -dependent DC deflection and the arterial pH. Our findings corresponded to a slope of 16.1 mV/pH unit which is very similar.
DHC-induced BBB opening to albumin is neither associated with a measureable increase of baseline [K + ] o nor a change in the CO 2 -dependent intracortical DC deflection (preparation type 2)
To test the hypothesis that BBB opening to macromolecules such as albumin is associated with (i) BBB opening to small molecules such as potassium, (ii) disappearance of the potential difference between intravascular and interstitial space, and, hence, (iii) disappearance of the CO 2 -dependent intracortical DC deflection, the bile salt DHC was topically applied to the brain at a concentration of 2 mM (n = 9). At this comparably low concentration, DHC causes Evans blue dye extravasation and has no obvious acute neurotoxic effects in vivo or in vitro (Seiffert et al., 2004) . Before DHC application, the response to hypercapnia was tested twice at an interval of 30 min. Then, Evans blue was given intravenously followed by brain topical application of DHC for 90 min. A third hypercapnic episode was induced at 90 min. There were no significant differences in p a CO 2 , p a O 2 , arterial pH or MAP between the three hypercapnic episodes (one way repeated measures analysis of variance). Moreover, no difference was detected between the three hypercapnia-induced intracortical DC-deflections (1st hypercapnia: 2.9 (2.7, 3.4) mV, 2nd hypercapnia: 2.8 (2.5, 3.1) mV, 3rd hypercapnia under DHC: 2.9 (2.8, 3.3) mV, n = 9, one way repeated measures analysis of variance, Fig. 6A ). During DHC application, rCBF increased slowly and significantly from 105 (99, 106) % to 139 (132, 177) % (P = 0.006, n = 8, Paired t-test) but this was also the case in the control group in which rCBF increased from 104 (97, 113) % to 147 (116, 170) % (P = 0.030, n = 7, Paired t-test). Possibly, this was due to a slight decline in sedation depth since, after pooling the data of both the control and DHC group, the power of the spontaneous activity significantly increased over time from 5.5 (3.8, 7.0) to 7.7 (5.0, 12.3) mV 2 Fig. 5 . Comparison between the CO 2 -dependent intracortical DC deflections in vitro and in vivo. (A) In brain slices, hypercapnia (bars, change from 80% O 2 , 5% CO 2 , and 15% N 2 to 80% O 2 , 20% CO 2 and 0% N 2 ) induced a small negative intracortical DC deflection in contrast to the positive DC deflection in vivo (B). This negative CO 2 -dependent intracortical DC deflection in the slices might be generated by astrocytes in contrast to the positive CO 2 -dependent intracortical DC deflection in vivo as explained in the Supplemental Discussion (6: Why the CO 2 -dependent intracortical DC deflection is not of astrocytic origin). ] o was 2.9 (2.7, 3.5) before and 3.0 (2.6, 3.4) mM after DHC application (n = 6).
BBB opening to albumin was assessed by calculating the target to background ratio of relative Evans blue dye extravasation in the cranial window region compared to the corresponding region of the contralateral hemisphere (Figs. 6B and C). Brain topical application of DHC led to a significant increase in Evans blue extravasation (target to background ratio: 1.44 (1.37, 1.49), n = 9) compared to the sham operated group (target to background ratio: 1.12 (1.11, 1.14), n = 6) (P = 0.002, Mann-Whitney Rank Sum test) similar to previous observations (Seiffert et al., 2004) . In 16 animals, mannitol (1.6 M, 1 ml) was administered via the right carotid artery to open the BBB transiently in the vascular territory of this artery. While mannitol was applied, Evans blue was already present intravenously to allow us the quantification of the local BBB opening to albumin ex vivo later on. Mannitol led to an acidification of the blood to a pH of~7.1 as measured ex vivo and induced a significant, transient positive DC deflection of 2.1 (1.7, 2.8) mV (P b 0.001, Paired t-test) and a significant, transient rise in rCBF from 110 (96, 138) to 544 (277, 655) % (P b 0.001, Mann-Whitney Rank Sum Test) after application to the carotid artery (Figs. 7A and B) . No change in baseline [K + ] o was observed, but six animals generated SD in response to mannitol as shown in Fig. 7B . This was never observed in response to intracarotideal application of physiological NaCl (n = 16). The SD in response to mannitol was characterized by a sharp negative intracortical DC-shift of − 11.3 (− 13.8, − 9.7) mV lasting for 42 (41, 50) (Fig. 7C) .
The positive CO 2 -dependent intracortical DC deflections before and after mannitol application were not different in either animals displaying or not displaying SD (animals displaying SD, first and second hypercapnia before mannitol and third hypercapnia after mannitol: 3.7 (3.3, 3.9) mV versus 4.2 (3.7, 4.2) mV versus 4.1 (4.0, 5.0) mV, n =5, one way repeated measures analysis of variance) (animals not displaying SD, first and second hypercapnia before mannitol and third hypercapnia after mannitol: 3.1 (3.1, 3.2) mV versus 3.3 (2.9, 3.4) mV versus 3.7 (3.4, 4.2) mV, n = 9, one way repeated measures analysis of variance).
We then determined separately the target to background ratio of relative Evans blue dye extravasation between the ipsi-and contralateral hemisphere for animals which had or, respectively, had not displayed SD in response to mannitol (Fig. 7D) . Moreover, we performed five additional experiments in which SD was triggered by droplets of 300 mM KCl solution at a remote window but no mannitol was applied into the carotid artery. Animals which had not displayed SD in response to mannitol showed statistically significant Evans blue dye extravasation in the ipsilateral hemisphere (target to background ratio: 1.05 (1.02, 1.11), P = 0.003, n = 9, Mann-Whitney Rank Sum Test) in a similar fashion to animals in which SD was triggered by KCl but no mannitol was given (target to background ratio: 1.04 (1.02, 1.05), P = 0.027, n = 5, Paired t-test). However, animals which displayed SD in response to mannitol showed a significantly larger target to background ratio than the other two groups (target to background ratio: 1.34 (1.17, 1.44), P = 0.05, n = 6, Kruskal-Wallis one way analysis of variance on ranks with Dunn's post-hoc test). Fig. 1B for the experimental paradigm) which led to a shallow, transient DC positivity. After 90 min of superfusion with DHC, a third hypercapnic episode was induced. The CO 2 -dependent intracortical DC deflection after DHC was not different from the two CO 2 -dependent DC deflections before DHC. (B) Coronal section which shows the Evans blue dye extravasation in the cranial window area after topical application of DHC (bluish area). The Evans blue extravasation was assessed by calculating the target to background ratio of relative Evans blue extravasation in the area of the cranial window (target, blue square) compared to the corresponding region of the contralateral hemisphere (background, contralateral white square). The two white squares at the bottom indicate two regions which were provided by the algorithm and used to normalize the median light intensity of each hemisphere. (C) The difference in the target to background ratio was significant between sham controls (n = 6) and animals treated with topical DHC (n = 9) (*P = 0.002, Mann-Whitney rank sum test). (D) Prominent Evans blue extravasation in the ipsilateral hemisphere (blue area) after intracarotideal application of mannitol.
Discussion
All tools for the assessment of BBB function in vivo are subject to constraints by the complexity of the in vivo situation. This applies in particular to the assessment of the electrical barrier and has led to a number of in vitro models of BBB ion transport (Keep et al., 1993) . However, to confirm and understand the physiological and pathophysiological significance of the results of such in vitro studies, it is ultimately necessary to return to in vivo models. Application of DHC into the carotid artery has been proposed as such an in vivo model (Spigelman et al., 1983) which could be of particular interest to study the electrophysiological stigmata of electrical barrier disruption (Nita et al., 2004) . Our experiments in rats cast however doubt on this hypothesis because we recorded changes in rCBF and intracortical potentials typical of focal cerebral ischemia following intracarotideal DHC, and our morphological assessment of the brains showed a thrombosis of the middle cerebral artery. Severe damage of the endothelium by the high concentration of the bile salt DHC in the cerebral arteries might have led to endothelial injury and a consequent thrombosis (Lossinsky et al., 1995) . We cannot say with certainty that a similar thrombotic process also occurred in the previous study in cats (Nita et al., 2004) but the reported electrophysiological anomalies could reflect an ischemic process which is further discussed in the Supplemental Discussion (2: Electrophysiological anomalies following intracarotideal DHC in cats and rats).
These observations suggest that intracarotideal DHC is not a suitable model to selectively study the potential changes following the opening of the electrical barrier and they also illustrate an important pitfall when in vitro work on the BBB is translated into in vivo work, which is the induction of ischemic stroke as a consequence of severe damage to the BBB (Lossinsky et al., 1995) .
Morphological evidence that BBB dysfunction develops in a hierarchical fashion
According to previous electron microscopic studies, BBB dysfunction to hyperosmolar agents develops in a hierarchical fashion in which, first, the transcellular pathway is disturbed, causing increased brain influx of macromolecules, whereas the impairment of the paracellular pathway only constitutes the severe degree of damage (Farrell and Shivers, 1984; Houthoff et al., 1982; Lossinsky et al., 1995) . Only the latter should be associated with the opening of the electrical barrier.
In support of such a hierarchy of damage, a recent tracer study indicated that it is not possible to grade the dysfunction of the BBB according to the size of trespassing molecules. Thus, the signal enhancement by Gadofluorine M, a gadolinium formulation which binds quantitatively to albumin, extended beyond the lesion, but signal enhancement by gadolinium diethylenetriamine-pentaacetic acid (Gd-DTPA), a comparably small molecule without binding affinity to albumin, was restricted to the lesion, when the compounds were injected within 24 h following photothrombosis in rats (Stoll et al., 2009) .
Moreover, a previous study in adult viable pericyte-deficient mouse mutants indicated that the transcellular pathway can be severely disturbed in the presence of an intact paracellular pathway (Armulik et al., 2010) . This study found a marked increase in permeability of the BBB to water and a range of low-and highmolecular-mass tracers due to a selective increase in endothelial transcytosis while the integrity of the endothelial junctions was retained.
In the present paper, we investigated whether functional evidence can be found for this hierarchy of damage. The intactness of the electrical barrier was assessed using two functional tests, the stability of [K + ] o and the CO 2 -dependent intracortical DC deflection.
The electrical barrier can remain closed for potassium despite significant extravasation of Evans blue
In the Supplemental Discussion (3: Why the potassium equilibrium potential across the BBB implies an electrochemical driving force for potassium from the intravascular to the extracellular compartment) it is explained in detail why the trans-BBB gradient in potassium from 5 mM intravascularly to~3 mM interstitially leads to an electrochemical driving force for potassium from the intravascular to the interstitial compartment. This electrochemical driving force implies that an increase in (Figs. 6 and 7) . These findings hence provide functional evidence that opening of the BBB to macromolecules can occur without simultaneous opening to small ions such as potassium, consistent with the previous electron microscopic findings of intact tight junctions despite significant morphological anomalies of the transcellular pathway, when the BBB dysfunction was mild to moderate following the exposure to hyperosmolar solutions (Farrell and Shivers, 1984; Houthoff et al., 1982; Lossinsky et al., 1995 ] o be undetectable when the potassium is derived from the blood instead of neurons? It could be argued that the electrical barrier opened too slowly in the experiments in which DHC was topically applied and this gave astrocytes enough time to adapt to the brain influx of potassium but this argument does not hold for the intracarotideal application of mannitol (Lossinsky et al., 1995) . We cannot exclude with absolute certainty that [K + ] o only increased in tissue patches where no microelectrodes were placed (Somjen et al., 1991) . But, we believe this is not very likely because we did not find an increase in [K + ] o in any of the 16 experiments with intracarotideal mannitol and the six experiments with topical DHC in which two potassium-selective microelectrodes were positioned in the interstitial space.
Interestingly, mannitol induced SD in a fraction of experiments. The possible mechanisms underlying this observation are further discussed in the Supplemental Discussion (4: The induction of SD by mannitol).
The CO 2 -dependent intracortical DC deflection
In the present study, both the experiments in brain slices and the negative results of the pharmacological experiments in vivo strongly supported the prevailing view that the CO 2 -dependent intracortical DC deflection is not generated by neurons or astrocytes (Lehmenkühler et al., 1999; Voipio et al., 2003; Woody et al., 1970) . This is further explained in detail in the Supplemental Discussion (5: Why the CO 2 -dependent intracortical DC deflection is not of neuronal origin; 6: Why the CO 2 -dependent intracortical DC deflection is not of astrocytic origin). Instead there appears to be general agreement that the CO 2 -dependent intracortical DC deflection is generated at the BBB and that, specifically in rats, similarly to rabbits, goats and dogs, it is a diffusion potential related to the proton gradient across the BBB on which it depended in a linear fashion in previous studies (Held et al., 1964; Messeter and Siesjo, 1971; Tschirgi and Taylor, 1958) . The arguments for this hypothesis are presented in the Supplemental Discussion (7: Generation of the CO 2 -dependent intracortical DC deflection at the BBB) based on the present and previous observations.
When we either applied DHC topically to the brain or mannitol into the carotid artery, we did not find any decline in the CO 2 -dependent intracortical DC deflection although the tissue displayed significant Evans blue dye extravasation. If tight junctions had opened for small ions including protons, a decline should have been detectable. This finding hence provides additional evidence, independent of the measurements of [K + ] o , that the electrical barrier remained intact. The caveat could be added that the opening of the electrical barrier could have been so short-lasting that we missed it when we exposed the animals to hypercapnia a few minutes after the intracarotideal application of mannitol. However, mannitol led to an acidification of the blood. Consistently, mannitol caused a significant, short-lasting, positive intracortical DC deflection during its application. If the electrical barrier had opened during this period, we should have seen a negative rather than a positive DC potential because the extracellular compartment is electropositive to the intravascular compartment under normal resting conditions (Held et al., 1964; Messeter and Siesjo, 1971; Revest et al., 1994) . This makes it very unlikely that we missed a short-lasting opening of the electrical barrier. Moreover, earlier reports indicated that the dysfunction of the BBB following mannitol recovers only slowly, after an hour or more (Hardebo, 1980; Rapoport et al., 1980; Somjen et al., 1991) .
At least partially, the acidification of the blood might have also been responsible for the marked increase in rCBF during application of mannitol because acidosis causes vasodilation, and vasodilation increases rCBF (Lindauer et al., 2003) . Alternatively, BBB dysfunction could have been responsible for this acute increase in rCBF. Our DHC experiments were however not consistent with the latter hypothesis. In contrast to the mannitol experiments, the increase in rCBF following topical application of DHC to the brain was not larger than the rCBF increase in the control experiments. The relationship between BBB dysfunction and rCBF, the implications of rCBF changes for measurements of the transendothelial electrical resistance and possible interactions between rCBF and our recordings of extracerebral potentials are further discussed in the Supplemental Discussion (8: BBB dysfunction and rCBF, implications of changes in rCBF for the transendothelial electrical resistance; 9: Interactions between rCBF and DC potential changes).
Conclusion
In the present study, we found further evidence that the CO 2 -dependent intracortical DC-deflection is generated at the BBB, which provides a simple and robust tool to test the integrity of the electrical barrier in rats in vivo. Notably, our data indicate that opening of the BBB to macromolecules such as albumin is not necessarily associated with free permeability of the BBB to small ions such as potassium and protons and a short-circuit between intravascular and interstitial space, respectively. Our data hence appear to confirm a hierarchy of damage previously found in electron microscopic studies in which the dysfunction of the transcellular pathway preceded the dysfunction of the paracellular pathway (Farrell and Shivers, 1984; Houthoff et al., 1982; Lossinsky et al., 1995) . Clinically, this implies that changes in p a CO 2 may induce cerebral DC potential changes in patients with acute cerebral injuries although neuroimaging studies indicate BBB dysfunction. CO 2 -dependent DC deflections could particularly confound the assessment of ultraslow injury potentials which are increasingly important in the neuromonitoring of patients on the intensive care unit because they appear to indicate the occurrence of a new stroke (Dreier et al., 2013; Drenckhahn et al., 2012) . Moreover, we suggest that severe BBB damage is an etiology of ischemic stroke and may be an important obstacle for strategies of drug targeting in the brain which aim at the opening of the BBB. This deserves further careful experimental and clinical studies.
Supplementary data to this article can be found online at http:// dx.doi.org/10.1016/j.nbd.2012.12.007.
